These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36656396)

  • 1. Schizophrenia as metabolic disease. What are the causes?
    Helaly AMN; Ghorab DSED
    Metab Brain Dis; 2023 Mar; 38(3):795-804. PubMed ID: 36656396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial medicine--recent advances.
    Graff C; Clayton DA; Larsson NG
    J Intern Med; 1999 Jul; 246(1):11-23. PubMed ID: 10447221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte Proteomic Profiling in First-Episode Schizophrenia Patients: Does Oxidative Stress Play Central Roles in the Pathophysiology Network of Schizophrenia?
    Jiang J; Peng C; Sun L; Li J; Qing Y; Hu X; Yang X; Li Y; Xu C; Zhang J; Min J; Li X; Qin S; Lin M; Tan L; Wan C
    Antioxid Redox Signal; 2019 Sep; 31(8):579-588. PubMed ID: 31126188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC-1α regulate critical period plasticity via gene × environment interaction in the developmental trajectory to schizophrenia.
    Wang J; Song HR; Guo MN; Ma SF; Yun Q; Liu WJ; Hu YM; Zhu YQ
    Biochem Biophys Res Commun; 2020 May; 525(4):989-996. PubMed ID: 32173526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
    Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
    Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.
    Kim SY; Cohen BM; Chen X; Lukas SE; Shinn AK; Yuksel AC; Li T; Du F; Öngür D
    Schizophr Bull; 2017 Jan; 43(1):197-204. PubMed ID: 27665001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.
    Ben-Shachar D
    J Neural Transm (Vienna); 2020 Feb; 127(2):159-168. PubMed ID: 31848775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia.
    McKinney BC; Lin H; Ding Y; Lewis DA; Sweet RA
    Schizophr Res; 2018 Jun; 196():39-44. PubMed ID: 28988914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia.
    Maas DA; Vallès A; Martens GJM
    Transl Psychiatry; 2017 Jul; 7(7):e1171. PubMed ID: 28934193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.
    Kulak A; Steullet P; Cabungcal JH; Werge T; Ingason A; Cuenod M; Do KQ
    Antioxid Redox Signal; 2013 Apr; 18(12):1428-43. PubMed ID: 22938092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial diseases in man and mouse.
    Wallace DC
    Science; 1999 Mar; 283(5407):1482-8. PubMed ID: 10066162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.
    Wallace DC
    Annu Rev Genet; 2005; 39():359-407. PubMed ID: 16285865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated aging signatures in subjects with schizophrenia and their unaffected siblings.
    Rebouças DB; Sartori JM; Librenza-Garcia D; Rabelo-da-Ponte FD; Massuda R; Czepielewski LS; Passos IC; Gama CS
    J Psychiatr Res; 2021 Jul; 139():30-37. PubMed ID: 34022473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia.
    Beeraka NM; Avila-Rodriguez MF; Aliev G
    Mol Neurobiol; 2022 Apr; 59(4):2472-2496. PubMed ID: 35083660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox regulation of microRNAs in health and disease.
    Siow RC; J Forman H
    Free Radic Biol Med; 2013 Sep; 64():1-3. PubMed ID: 23880294
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitochondrial dysfunction in metabolism and ageing: shared mechanisms and outcomes?
    López-Lluch G; Hernández-Camacho JD; Fernández-Ayala DJM; Navas P
    Biogerontology; 2018 Dec; 19(6):461-480. PubMed ID: 30143941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction to Special Issue on Mitochondrial Redox Signaling in Health and Disease.
    Bolaños JP; Cadenas E; Duchen MR; Hampton MB; Mann GE; Murphy MP
    Free Radic Biol Med; 2016 Nov; 100():1-4. PubMed ID: 27502830
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial proteomics--a tool for the study of metabolic disorders.
    Gregersen N; Hansen J; Palmfeldt J
    J Inherit Metab Dis; 2012 Jul; 35(4):715-26. PubMed ID: 22526845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria and cellular redox state on the route from ageing to Alzheimer's disease.
    Abate G; Vezzoli M; Sandri M; Rungratanawanich W; Memo M; Uberti D
    Mech Ageing Dev; 2020 Dec; 192():111385. PubMed ID: 33129798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and gut-flora related epigenetic factors.
    Zhuo C; Yao Y; Xu Y; Liu C; Chen M; Ji F; Li J; Tian H; Jiang D; Lin C; Chen C
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():49-54. PubMed ID: 30419320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.